ANTH
Anthera Pharmaceuticals, Inc.
ANTH
ANTH
Delisted
ANTH was delisted on the 27th of June, 2018.
32 hedge funds and large institutions have $35.7M invested in Anthera Pharmaceuticals, Inc. in 2013 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
32
Holders Change
-3
Holders Change %
-8.57%
% of All Funds
1.04%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
6
Increased
10
Reduced
10
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
MCM
Moore Capital Management
New York
|
-$926K |
| 2 |
VM
VHCP Management
New York
|
-$666K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$614K |
| 4 |
JGC
J. Goldman & Co
New York
|
-$463K |
| 5 |
B
Bailard
Foster City,
California
|
-$265K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BA
26
BlackRock Advisors
Wilmington,
Delaware
| $14K | +$9.12K | +290 | +187% |
|
27
Dimensional Fund Advisors
Austin,
Texas
| $14K | +$14K | +435 | New |
|
28
Bank of America
Charlotte,
North Carolina
| $5K | -$994 | -31 | -17% |
|
29
California Public Employees Retirement System
Sacramento,
California
| $3K | – | – | – |
|
|
MCM
30
Moore Capital Management
New York
| – | -$926K | -31,250 | Closed |
|
|
VM
31
VHCP Management
New York
| – | -$666K | -22,463 | Closed |
|
|
JGC
32
J. Goldman & Co
New York
| – | -$463K | -15,625 | Closed |
|
|
OAM
33
Oxford Asset Management
Oxford,
United Kingdom
| – | -$37K | -1,258 | Closed |
|
|
GC
34
Guggenheim Capital
Chicago,
Illinois
| – | -$21K | -712 | Closed |
|
35
State Street
Boston,
Massachusetts
| – | -$17K | -595 | Closed |
|
36
Nomura Holdings
Tokyo,
Japan
| – | -$9K | -214 | Closed |
|
37
Morgan Stanley
New York
| – | -$5K | -156 | Closed |
|